Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Dual degradation of aurora A and B kinases by the histone deacetylase inhibitor LBH589 induces G2-M arrest and apoptosis of renal cancer cellsTai-Lung Cha, Mei-Jen Chuang, Sheng-Tang Wu, et al.Diagnostics (Basel, Switzerland)|March 29, 2023
Circulating Tumor Cells Predict Response of Neoadjuvant Chemotherapy in Patients with Bladder Cancer: A Preliminary StudyYu-Cing Jhuo, Tai-Lung Cha, Chien-Chang Kao, et al.Plos One|September 12, 2013
The HDAC inhibitor LBH589 induces ERK-dependent prometaphase arrest in prostate cancer via HDAC6 inactivation and down-regulationMei-Jen Chuang, Sheng-Tang Wu, Shou-Hung Tang, et al.Molecular Carcinogenesis|October 12, 2013
Emodin modulates epigenetic modifications and suppresses bladder carcinoma cell growthTai-Lung Cha, Mei-Jen Chuang, Shou-Hung Tang, et al.Biology|August 6, 2021
Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells as a Predictor of Treatment Response in Patients with Urothelial CarcinomaPei-Jhang Chiang, Ting Xu, Tai-Lung Cha, et al.Journal of the Chinese Medical Association : JCMA|October 26, 2021
Detection of circulating tumor cells as therapeutic markers in patients with penile squamous cell carcinoma: A preliminary studyChien-Chang Kao, Ting Xu, Yung-Ning Yang, et al.Medicina (Kaunas, Lithuania)|March 27, 2025
A Novel Hybrid Approach to Manage Mycotic Pseudoaneurysm Post-Renal Transplantation: Successful Graft PreservationHo Li, Yi-Chang Lin, Chien-Chang Kao, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|February 8, 2022
Determining programmed cell death ligand 1 expression in circulating tumor cells of patients with clear cell renal cell carcinoma and its correlation with response to programmed cell death protein 1 inhibitorsBo-Han Chen, Chien-Chang Kao, Ting Xu, et al.Cancer Research|June 24, 2015
Novel Cancer Therapeutics with Allosteric Modulation of the Mitochondrial C-Raf-DAPK Complex by Raf Inhibitor Combination TherapyYi-Ta Tsai, Mei-Jen Chuang, Shou-Hung Tang, et al.Cancer Research|August 29, 2025
MYADM Activates RhoA-Mediated Amoeboid Migration to Drive MetastasisYi-Ta Tsai, En-Ting Liu, Ming-Hsin Yang, et al.Pageof 5